Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · September 27, 2024

ESMO 2024: T-DXd Yields Significant Intracranial Response in Patients With HER2-Positive Metastatic Breast Cancer With Brain Metastases

Twelve-month progression-free survival was 61.6% among patients with stable and active brain metastases

PracticeUpdate Editorial Team

 

Further Reading